MBRX - Moleculin Biotech Stock Trading

Moleculin Biotech Inc.(NASDAQ: MBRX) stock trading description contact officers and directors.

About Moleculin Biotech Inc.

Not available

Stock Information

Moleculin Biotech Inc. Company Name:

MBRX Stock Symbol:

NASDAQ Market:

Moleculin Biotech Inc. Website:

Get MBRX Alerts

News, Short Squeeze, Breakout and More Instantly...

MBRX - Moleculin Concludes Phase 1b and Opens Recruitment in Phase 2 Clinical Trial of Annamycin for the Treatment of Soft Tissue Sarcoma Lung Metastases

Moleculin Concludes Phase 1b and Opens Recruitment in Phase 2 Clinical Trial of Annamycin for the Treatment of Soft Tissue Sarcoma Lung Metastases PR Newswire – Preliminary Phase 1b data demonstrated clinical activity, defined as stable disease or better ...
MBRX - Moleculin Announces Completion of Second Single Ascending Dose (SAD) Cohort in Phase 1a Clinical Trial of WP1122 in the UK

Moleculin Announces Completion of Second Single Ascending Dose (SAD) Cohort in Phase 1a Clinical Trial of WP1122 in the UK PR Newswire – Preliminary results of second cohort in the first-in-human Phase 1a allow Company to proceed to 32 mg/kg dose of WP1122 in th...
MBRX - Moleculin Announces Completion of First Single Ascending Dose (SAD) Cohort in Phase 1a Clinical Trial of WP1122 in the UK

Moleculin Announces Completion of First Single Ascending Dose (SAD) Cohort in Phase 1a Clinical Trial of WP1122 in the UK PR Newswire – Preliminary results of first cohort in the first-in-human Phase 1a allows Company to proceed to 16 mg/kg dose of WP1122 in...